Ankit Bhatta

Ankit Bhatta is a skilled scientist with extensive experience in immunology and molecular medicine. Currently employed at CERo Therapeutics, Inc. since May 2019, Ankit has held positions as Scientist, Associate Scientist, and Research Associate, engaging in in vitro biophysical and cell-based binding assays. Prior experience includes a role as Research Associate II at Five Prime Therapeutics, Inc., where Ankit performed immune-relevant functional assays. Ankit's tenure at MD Anderson Cancer Center involved immune-monitoring of tumor infiltrating lymphocytes in clinical trials, while earlier work at the University of Maryland, Baltimore encompassed managing flow cytometry experiments and research on IL15 and IL15Rα splice variants in celiac disease. Ankit holds a Master of Science in Molecular Medicine from the University of Maryland Baltimore and a Bachelor of Science in Microbiology from Fergusson College.